GLOBAL RENAL MASS STUDY – A PROSPECTIVE INTERNATIONAL STUDY ON INDICATIONS, TREATMENT MODALITIES AND OUTCOMES.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON24563

Enrollment

5000

Registered

2009-11-18

Start date

2010-01-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Mass

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Each centre participating in this project will include during a one-year period all the patients treated at their site, with a diagnosis of a renal tumour or candidates for active surveillance (AS).

Exclusion criteria

Exclusion criteria: None.

Design outcomes

Primary

Measure	Time frame
To assess the current patterns of surgical or instrumental treatment and indications for RCC treatment.	—

Secondary

Measure	Time frame
1. To assess perioperative morbidity (30 days) by using the Clavien score; 2. To assess operative complications; 3. To define risk factors for the development of operative and peri-operative morbidity after instrumental treatment; 4. To asses the long term risk of renal insufficiency; 5. To asses pathological characteristics of the renal masses.	—

Contacts

Public ContactSonja Rees Vellinga, van

info@croesoffice.org+31 (0)20 56 66377

Outcome results